Intelligent Group Resolves Nasdaq Bid Price Deficiency, Listing Secured
Rhea-AI Filing Summary
Intelligent Group Limited (INTJ) has resolved its Nasdaq bid-price deficiency. The company received a Nasdaq notice on 20 Feb 2025 for trading below the $1.00 minimum for 30 consecutive business days. Nasdaq granted an 180-day cure period ending 19 Aug 2025.
On 18 Jul 2025, Nasdaq confirmed that INTJ’s Class A ordinary shares closed at or above $1.00 for 10 straight trading days (3–17 Jul 2025). This restores full compliance with Listing Rule 5550(a)(2) and closes the deficiency case. A confirming press release dated 21 Jul 2025 is furnished as Exhibit 99.1.
Regaining compliance removes the near-term delisting threat but does not address the fundamental factors that allowed the share price to breach the $1 threshold earlier.
Positive
- None.
Negative
- None.
Insights
TL;DR: Compliance regained; delisting risk lifted, modest positive sentiment.
Nasdaq’s confirmation eliminates an immediate overhang that could have triggered forced selling by institutional mandates. Although no financial metrics were provided, maintaining the listing protects liquidity, investor access, and index eligibility. The move may support short-term share price stability; however, the narrow margin above $1 signals that management still faces pressure to improve fundamentals and trading volume.
TL;DR: Governance compliance restored, but vigilance required.
The board averted potential delisting, which would have impaired capital-raising options and shareholder value. Timely disclosure and press release show adherence to transparency norms. Still, the recurrence risk remains unless strategic measures boost market capitalization and liquidity.